---
created: 2025-04-13
updated: 2025-04-13T10:52
id: v4jA}V?R!+
specialty: pharmaco
specialty_id: 75
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - "source/ak-step1-v11:": 
  - theme/b&b::18-pulm::02-obstructive-&-restrictive-diseases::04-treatment-of-copd-&-asthma
  - "source/ak-step1-v11:": 
  - theme/firstaid::02-immunology::04-immunosuppressants::04-therapeutic-antibodies
  - "source/ak-step1-v11:": 
  - theme/firstaid::02-immunology::04-immunosuppressants::04-therapeutic-antibodies::omalizumab
  - "source/ak-step1-v11:": 
  - theme/firstaid::16-respiratory::05-pharm::07-asthma-drugs
  - "source/ak-step1-v11:": 
  - theme/firstaid::16-respiratory::05-pharm::07-asthma-drugs::anti-ige-monoclonal-therapy
  - "source/ak-step1-v11:": 
  - source/ome-banner::basic-science::04-general-physiology::14-smooth-muscle
  - "source/ak-step1-v11:": 
  - theme/physeo::09-pharm::08-respiratory::06-asthma-treatment
  - "source/ak-step1-v11:": 
  - theme/physeo::09-pharm::08-respiratory::07-alternative-asthma-treatment
  - "source/ak-step1-v11:": 
  - theme/pixorize::03-pharm::19-respiratory::omalizumab
  - "source/ak-step1-v11:": 
  - theme/sketchypharm::04-smooth-muscle::02-allergy-&-pulmonary::02-asthma-therapy
  - "source/ak-step1-v11:": 
  - theme/uworld::1000-9999::2000-2999::2128
  - source/ak-step1-v11::^other::^highyield::2-relativelyhighyield
  - source/ak-step1-v11::^systems::respiratory::pharmacology
  - "source/ak-step2-v11:": 
  - theme/b&b::07-pulmonary::01-pulmonary-disease::02-asthma"
type: flashcard
---

# Question
**Omalizumab** is a monoclonal antibody directed against the **Fc** portion of **IgE**, preventing mast cell sensitization

---

# Answer
